Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Mosseri Marlio Charles | 10% | P Purchase | — | $18.32 | $916K | filing |
| Jul 1, 2026 | Bentsur Ron | COB, CEO, 10% | P Purchase | — | $20.00 | $250K | filing |
NUVECTIS PHARMA INC (NVCT) insider trading activity (SEC Form 4). Over the trailing 90 days, NVCT insiders filed 2 purchases totalling $1.2M and 0 sales totalling $0 — net BUYING of $1.2M. Most recent filing: Jul 1, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.